Michael Reardon, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1174523229
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $492,568 of the $712,859 with a category attached, or 69.1%. Medtronic accounts for 83.0% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $180,410 and has fallen 64.4% since, to $64,238 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 860 payments — averaging $828.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$592K
- Abbott$50K
- W. L. Gore & Associates, Inc.$29K
- Boston Scientific$25K
- Admedus Corporation$8K
- Edwards Lifesciences$5K
- plus $5K from 26 others
Across 249 payments — averaging $8027.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.6M
- Boston Scientific$206K
- Edwards Lifesciences$98K
- Abbott$54K
What the payments were for
- Consulting fees$73,10810%
- Speaking & faculty fees$492,56869%
- Grants$1,1230%
- Travel & lodging$120,25717%
- Food & beverage$25,2964%
- Education$2250%
- Other$2820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 584 | $591,526 |
| Abbott | 91 | $49,771 |
| W. L. Gore & Associates, Inc. | 35 | $28,628 |
| Boston Scientific | 45 | $24,809 |
| Admedus Corporation | 1 | $8,000 |
| Edwards Lifesciences | 51 | $4,850 |
| Baylis Medical Company Inc | 1 | $2,500 |
| Baxter Healthcare | 9 | $858 |
| Abiomed | 5 | $513 |
| Medinc Of Texas | 3 | $273 |
| Atricure, Inc. | 2 | $184 |
| Inari Medical, Inc. | 1 | $123 |
| Livanova USA, Inc. | 1 | $93 |
| Corcym Inc | 1 | $92 |
| Cook Medical LLC | 4 | $74 |
| Lemaitre Vascular, Inc. | 3 | $74 |
| Getinge USA Sales, LLC | 6 | $72 |
| Surmodics, Inc. | 2 | $70 |
| Angiodynamics, Inc. | 1 | $60 |
| Imperative Care, Inc | 1 | $44 |
| Johnson & Johnson | 2 | $35 |
| Jenavalve Technology, Inc. | 1 | $33 |
| Bolton Medical Inc | 1 | $30 |
| Kls-martin L.p. | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| Biom'up SA | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $19 |
| Amgen | 1 | $18 |
| Biom'up France SAS | 1 | $16 |
| Acell, Inc. | 1 | $15 |
| Inceptus Medical, LLC | 1 | $9 |
| Alafair Biosciences, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$344,452
- CoreValve Evolut$146,522
- Avalus$30,029
- Product in Development$27,286
- Mitra Clip system$15,120
- NAVITOR$15,061
- PORTICO$5,194
- Portico Transcatheter Aortic HV$4,383
- GENERAL - STRUCTURAL HEART$3,933
- GENERAL - THERAPIES$2,654
- NRG needle$2,500
- MitraClip$1,704
- Hancock$1,104
- INSPIRIS RESILIA aortic valve$739
- Mosaic$729
- Simulus$563
- Conformable TAG Thoracic Endoprosthesis$453
- PREVELEAK$400
- MitraClip System$382
- FLOSEAL$375
How this compares
$712,859 in reported general payments places this provider in the 95th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Houston
- Danny RamzyHouston$527K
- Randall WolfHouston$283K
- Min KimHouston$185K
- Marc MoonHouston$142K
- Ismael Salas de ArmasHouston$121K
- Shawn GrothHouston$110K
- Mahesh RamchandaniHouston$110K
- Gabriel LoorHouston$106K
- Mara AntonoffHouston$104K
- Moritz Wyler von BallmoosHouston$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.